BIOMAT Database Logo BIOMAT Database Logo

Radioactive iron (59Fe) excretion through the urine and feces after intravenous iron-59 administration in congenital hemolytic anemias. 1967

H Gyftaki, and M Kesse-Elias, and M Constantoulakis, and B Malamos

UI MeSH Term Description Entries
D007503 Iron Isotopes Stable iron atoms that have the same atomic number as the element iron, but differ in atomic weight. Fe-54, 57, and 58 are stable iron isotopes. Isotopes, Iron
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000755 Anemia, Sickle Cell A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S. Hemoglobin S Disease,HbS Disease,Sickle Cell Anemia,Sickle Cell Disease,Sickle Cell Disorders,Sickling Disorder Due to Hemoglobin S,Anemias, Sickle Cell,Cell Disease, Sickle,Cell Diseases, Sickle,Cell Disorder, Sickle,Cell Disorders, Sickle,Disease, Hemoglobin S,Hemoglobin S Diseases,Sickle Cell Anemias,Sickle Cell Diseases,Sickle Cell Disorder
D013789 Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. Thalassemias

Related Publications

H Gyftaki, and M Kesse-Elias, and M Constantoulakis, and B Malamos
RADIOACTIVE IRON AND ITS EXCRETION IN URINE, BILE, AND FECES.
October 1939, The Journal of experimental medicine,
H Gyftaki, and M Kesse-Elias, and M Constantoulakis, and B Malamos
[Intestinal iron absorption. Studies with the 59Fe feces excretion method and the 59Fe-51Cr dilution method].
January 1970, Medizinische Klinik,
H Gyftaki, and M Kesse-Elias, and M Constantoulakis, and B Malamos
[Importance of examinations with radioactive iron 59 in the study of anemias in children].
January 1966, Marseille medical,
H Gyftaki, and M Kesse-Elias, and M Constantoulakis, and B Malamos
Iron (59Fe) binding capacity in the diagnosis of anemias.
April 1968, Boletin de la Asociacion Medica de Puerto Rico,
H Gyftaki, and M Kesse-Elias, and M Constantoulakis, and B Malamos
Antibiotic activity in urine and feces after oral and intravenous administration of demethylchlortetracycline.
September 1960, The New England journal of medicine,
H Gyftaki, and M Kesse-Elias, and M Constantoulakis, and B Malamos
[Iron metabolism in the hemolytic anemias].
September 1952, Rassegna di fisiopatologia clinica e terapeutica,
H Gyftaki, and M Kesse-Elias, and M Constantoulakis, and B Malamos
Studies on the metabolites in urine and feces of rat after oral administration of radioactive pantethine.
September 1972, Chemical & pharmaceutical bulletin,
H Gyftaki, and M Kesse-Elias, and M Constantoulakis, and B Malamos
[IRON METABOLISM IN HEMOLYTIC ANEMIAS].
November 1964, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete,
H Gyftaki, and M Kesse-Elias, and M Constantoulakis, and B Malamos
Plasma iron levels and urinary iron excretion after the intravenous administration of different iron preparations.
December 1953, British journal of pharmacology and chemotherapy,
H Gyftaki, and M Kesse-Elias, and M Constantoulakis, and B Malamos
Hemolytic anemias: congenital and acquired.
April 1980, Hospital practice,
Copied contents to your clipboard!